Work

Machine Learning–Based Prediction of Stroke and Systemic Embolism in Patients with Atrial Fibrillation: A Comparative Real-World Study

Year: 2026
Type: article
Study design: Observational Study
Abstract: Background: Risk stratification for ischaemic stroke and systemic embolism in atrial fibrillation (AF) typically relies on clinical scores with predefined predictors. This study compared conventional CHA₂DS₂-VASc scoring with logistic regression and machine learning models using routine clinical data.Methods: A retrospective cohort of 248,500 adults with AF was identified in the TriNetX Global Collaborative Network from 2015 to 2025. Development and validation sets comprised 198,800 and 49,700 individuals, respectively. The primary outcome was ischaemic stroke or systemic embolism within 24 months. Discrimination, calibration, net benefit, and subgroup performance were evaluated.Results: A total of 12,425 events were recorded (5.0% of the baseline cohort); 221,680 participants had ascertainable 24-month outcome status (event proportion, 5.6%). In the validation analysis, XGBoost achieved the highest AUROC (0.842; 95% CI, 0.832–0.852), followed by random forest (0.826), support vector machine (0.811), and logistic regression (0.794), compared with 0.681 for CHA₂DS₂-VASc. The XGBoost–CHA₂DS₂-VASc difference in AUROC was 0.161 (95% CI, 0.145–0.177; p < .001). XGBoost had a Brier score of 0.041 and higher estimated net benefit across the evaluated 2%–15% risk thresholds.Conclusion: In this internal validation study, models incorporating multidimensional clinical data, particularly XGBoost, discriminated thromboembolic events more effectively than the conventional CHA₂DS₂-VASc score. The comparison highlights the potential contribution of clinical and laboratory variables to AF risk prediction; external validation remains necessary before clinical implementation.
Language: English
Field: Medicine
Open Access status: gold
OpenAlex ID: W7234806183
FWCI:
Cites:
Cited by:
Related to: 10